Hims & Hers Health, Inc. (HIMS) Operating Cash Flow CAGR:-15.17%(TTM)
The operating cash flow cagr for Hims & Hers Health, Inc. (HIMS) is -15.17% over the latest trailing 12-month period. Operating cash flow CAGR uses precomputed cash-flow statement history (cash from operations, before capital expenditures).
The operating cash flow CAGR for Hims & Hers Health, Inc. (HIMS) stock is -15.17% over the past 12 months. The 3 year CAGR is 393.68%The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Operating cash flow CAGR measures the compound annual growth rate of the cash Hims & Hers Health, Inc. generates from its core business operations, before capital expenditures, computed from rolling-twelve-month cash-flow statement history.
HIMS Operating Cash Flow CAGR Chart
Hims & Hers Health, Inc. (HIMS)
HIMS Quarterly Operating Cash Flow Growth (YoY)
Operating Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
HIMS Operating Cash Flow CAGR History
| Year | Start OCF | End OCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $251.08M | $300.01M | +$48.92M | +19.48% | +19.48% |
| 2024 | $73.48M | $251.08M | +$177.60M | +241.69% | +241.69% |
| 2023 | $-26.53M | $73.48M | +$100.01M | +0.00% | N/A |
| 2022 | $-34.41M | $-26.53M | +$7.88M | +0.00% | N/A |
| 2021 | $-2.48M | $-34.41M | $-31.93M | +0.00% | N/A |
| 2020 | $-74.87M | $-2.48M | +$72.39M | +0.00% | N/A |
Quarterly Operating Cash Flow: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $89.36M | +38.1% | -18.1% |
| Q4 2025 | $64.70M | -56.5% | -25.1% |
| Q3 2025 | $148.72M | +878.0% | +74.4% |
| Q2 2025 | -$19.12M | -117.5% | -135.7% |
| Q1 2025 | $109.09M | +26.3% | +322.2% |
| Q4 2024 | $86.39M | +1.3% | +293.0% |
| Q3 2024 | $85.27M | +59.1% | +238.5% |
| Q2 2024 | $53.59M | +107.4% | +218.5% |
| Q1 2024 | $25.84M | +17.5% | +172.5% |
| Q4 2023 | $21.98M | -12.7% | +427.2% |
| Q3 2023 | $25.19M | +49.7% | +320.9% |
| Q2 2023 | $16.83M | +77.4% | +363.2% |
| Q1 2023 | $9.48M | +241.1% | +148.9% |
| Q4 2022 | -$6.72M | -212.3% | -116.4% |
| Q3 2022 | $5.99M | +193.6% | +137.5% |
| Q2 2022 | -$6.39M | +67.0% | -1163.9% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum